Skip to Content
You are currently on the new version of our website. Access the old version .

Vaccines, Volume 3, Issue 2

2015 June - 14 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (14)

  • Review
  • Open Access
40 Citations
13,735 Views
23 Pages

The Promise of Preventive Cancer Vaccines

  • Pier-Luigi Lollini,
  • Federica Cavallo,
  • Patrizia Nanni and
  • Elena Quaglino

17 June 2015

Years of unsuccessful attempts at fighting established tumors with vaccines have taught us all that they are only able to truly impact patient survival when used in a preventive setting, as would normally be the case for traditional vaccines against...

(This article belongs to the Special Issue Cancer Vaccines)
  • Review
  • Open Access
23 Citations
10,100 Views
19 Pages

29 May 2015

The barriers presented by immune suppression in the ovarian tumor microenvironment present one of the biggest challenges to development of successful tumor vaccine strategies for prevention of disease recurrence and progression following primary sur...

(This article belongs to the Special Issue Cancer Vaccines)
  • Review
  • Open Access
35 Citations
10,807 Views
19 Pages

Emerging Vaccine Technologies

  • Rebecca J. Loomis and
  • Philip R. Johnson

26 May 2015

Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV),...

(This article belongs to the Special Issue Vaccine Vector)
  • Review
  • Open Access
16 Citations
10,290 Views
9 Pages

21 May 2015

Antibodies to immune checkpoints have entered the clinical arena and have been shown to provide a clinical benefit for metastatic melanoma and, possibly, for other tumors as well. In this review paper we summarize this therapeutic activity and under...

(This article belongs to the Special Issue Cancer Vaccines)
  • Review
  • Open Access
53 Citations
14,169 Views
12 Pages

Gavi HPV Programs: Application to Implementation

  • Celina M. Hanson,
  • Linda Eckert,
  • Paul Bloem and
  • Tania Cernuschi

20 May 2015

Developing countries disproportionately suffer from the burden of cervical cancer yet lack the resources to establish systematic screening programs that have resulted in significant reductions in morbidity and mortality in developed countries. Human...

(This article belongs to the Special Issue Vaccine Delivery)
  • Review
  • Open Access
127 Citations
17,100 Views
18 Pages

CpG Oligonucleotides as Cancer Vaccine Adjuvants

  • Hidekazu Shirota,
  • Debra Tross and
  • Dennis M. Klinman

8 May 2015

Adjuvants improve host responsiveness to co-delivered vaccines through a variety of mechanisms. Agents that trigger cells expressing Toll-like receptors (TLR) activate an innate immune response that enhances the induction of vaccine-specific immunity...

(This article belongs to the Special Issue Cancer Vaccines)
  • Review
  • Open Access
178 Citations
30,438 Views
17 Pages

24 April 2015

Influenza is a major respiratory pathogen causing annual outbreaks and occasional pandemics. Influenza vaccination is the major method of prophylaxis. Currently annual influenza vaccination is recommended for groups at high risk of complications from...

(This article belongs to the Special Issue Influenza Vaccines)
  • Review
  • Open Access
245 Citations
17,491 Views
29 Pages

Whole Tumor Antigen Vaccines: Where Are We?

  • Cheryl Lai-Lai Chiang,
  • George Coukos and
  • Lana E. Kandalaft

23 April 2015

With its vast amount of uncharacterized and characterized T cell epitopes available for activating CD4+ T helper and CD8+ cytotoxic lymphocytes simultaneously, whole tumor antigen represents an attractive alternative source of antigens as compared to...

  • Review
  • Open Access
575 Citations
52,007 Views
24 Pages

Vaccine Adjuvants: from 1920 to 2015 and Beyond

  • Alberta Di Pasquale,
  • Scott Preiss,
  • Fernanda Tavares Da Silva and
  • Nathalie Garçon

16 April 2015

The concept of stimulating the body’s immune response is the basis underlying vaccination. Vaccines act by initiating the innate immune response and activating antigen presenting cells (APCs), thereby inducing a protective adaptive immune response to...

  • Review
  • Open Access
3 Citations
6,758 Views
30 Pages

14 April 2015

Obtaining approval for a multinational vaccine trial from an ethics committee and the national competent authority of different Member States of the European Union (EU) is challenging under clinical trial Directive 2001/20/EC because of the differen...

  • Review
  • Open Access
35 Citations
19,448 Views
27 Pages

14 April 2015

Influenza A virus is a respiratory pathogen which causes both seasonal epidemics and occasional pandemics; infection continues to be a significant cause of mortality worldwide. Current influenza vaccines principally stimulate humoral immune responses...

(This article belongs to the Special Issue Influenza Vaccines)
  • Review
  • Open Access
46 Citations
10,719 Views
24 Pages

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head

  • Lidewij C. M. Wiersma,
  • Guus F. Rimmelzwaan and
  • Rory D. De Vries

26 March 2015

Influenza viruses have a huge impact on public health. Current influenza vaccines need to be updated annually and protect poorly against antigenic drift variants or novel emerging subtypes. Vaccination against influenza can be improved in two importa...

(This article belongs to the Special Issue Influenza Vaccines)
  • Article
  • Open Access
23 Citations
8,794 Views
18 Pages

24 March 2015

Tumor vaccine design requires prediction and validation of immunogenic MHC class I epitopes expressed by target cells as well as MHC class II epitopes expressed by antigen-presenting cells essential for the induction of optimal immune responses. Epit...

(This article belongs to the Special Issue Cancer Vaccines)
  • Article
  • Open Access
17 Citations
10,424 Views
18 Pages

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

  • Stephanie Van de Wall,
  • Mateusz Walczak,
  • Nienke Van Rooij,
  • Baukje-Nynke Hoogeboom and ,
  • Tjarko Meijerhof,
  • Hans W. Nijman and
  • Toos Daemen
  • + 2 authors+ 0 author

24 March 2015

The skin is an attractive organ for immunization because of the presence of antigen-presenting cells. Intradermal delivery via tattooing has demonstrated superior vaccine immunogenicity of DNA vaccines in comparison to conventional delivery methods....

XFacebookLinkedIn
Vaccines - ISSN 2076-393X